Recurrent Atrial Fibrillation
This trial is active, not recruiting.
|Sponsor||University of Cincinnati|
|Start date||August 2016|
|End date||August 2018|
|Trial size||40 participants|
|Trial identifier||NCT02898545, 2015-2478|
This study will evaluate the recurrence rates of atrial fibrillation that develops in the hospital following non cardiac procedures or surgeries or acute medical illnesses.
|Endpoint classification||efficacy study|
|Intervention model||parallel assignment|
Recurrence of atrial fibrillation
time frame: 28 days
Male or female participants at least 18 years old.
Inclusion Criteria: - Development of atrial fibrillation or flutter during a hospital stay following a non-cardiac procedure or acute medical illness - CHADS2VASc score of 2 or more Exclusion Criteria: - Prior history of atrial fibrillation of flutter - Requiring ventilator support or in shock - Acute decompensated heart failure or EF =/< 40% - Greater than mild valvular heart disease - Other structural heart disease such as more than mild LVH, constrictive or restrictive cardiomyopathy - Hyperthyroidism uncontrolled at the time of diagnosis if known - Pulmonary embolism that requires thrombolysis or resulted in shock - Use of antiarrhythmic drugs (class I or III) at the time of discharge - Cardiothoracic surgery in the last 6 months
|Official title||Recurrent Atrial Fibrillation|
|Description||Eligible individuals with no previous history of atrial fibrillation or flutter who develop a limited episode of atrial fibrillation during a hospital stay for an acute medical illness or non-cardiothoracic surgery or procedure. Patients will be monitored for a period of 1 month using Medtronic SEEQ monitors for recurrence. Subjects will self assign to wear the SEEQ monitor or standard of care. Individuals with implanted cardiac devices capable of detecting atrial fibrillation will also be included.|
Call for more information